Katelyn Lynch, PA
Physician Assistant · Lansing, MINPI 1194977330
Payments from drug & device makers
Across 117 payments — averaging $105.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$8K
- AstraZeneca$1K
- Medtronic$661
- Insulet Corporation$522
- Abbott$384
- Lilly USA, LLC$337
- plus $1K from 20 others
What the payments were for
- Consulting fees$2,88523%
- Speaking & faculty fees$3,70530%
- Travel & lodging$1,28710%
- Food & beverage$4,40536%
- Education$430%
- Other$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $8,051 |
| AstraZeneca(2 entities) | 18 | $1,106 |
| Medtronic | 9 | $661 |
| Insulet Corporation | 11 | $522 |
| Abbott | 10 | $384 |
| Lilly USA, LLC | 11 | $337 |
| Dexcom, Inc. | 5 | $312 |
| Bayer | 7 | $191 |
| Cequr Corporation | 3 | $134 |
| Tandem Diabetes Care, Inc. | 4 | $124 |
| Boehringer Ingelheim | 1 | $122 |
| Ascendis Pharma Endocrinology Inc | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Mannkind Corporation | 1 | $43 |
| Amgen | 2 | $37 |
| GRT US Holding, Inc. | 2 | $32 |
| Novartis | 1 | $30 |
| IBSA Pharma Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| RGH Enterprises LLC | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| BETA Bionics, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$5,376
- Saxenda$1,140
- Strensiq$425
- Omnipod$374
- MINIMED 780G$246
- FreeStyle Libre$194
- DEXCOM G7 GSS (161)$149
- JARDIANCE$122
- FARXIGA$116
How this compares
$12,355 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 284 | $529,432 |
| MounjaroTirzepatide | 262 | $406,965 |
| TrulicityDulaglutide | 221 | $389,433 |
| JardianceEmpagliflozin | 269 | $378,622 |
| FarxigaDapagliflozin Propanediol | 184 | $237,907 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 144 | $196,353 |
| Tresiba Flextouch U-200Insulin Degludec | 63 | $122,767 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 70 | $74,985 |
| Novolog FlexpenInsulin Aspart | 156 | $72,470 |
| RybelsusSemaglutide | 38 | $67,713 |
| Humalog Kwikpen U-100Insulin Lispro | 120 | $54,181 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 250 | $48,108 |
| InvokanaCanagliflozin | 46 | $46,879 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $43,961 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 12 | $25,695 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Baqsimi | $337 | $815,757536 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $8,051 | $620,176373 claims |
| Boehringer IngelheimJardiance | $122 | $378,622269 claims |
| AstraZenecaFarxiga | $1,106 | $237,907184 claims |
| BayerKerendia | $191 | $23,71013 claims |
| IBSA Pharma Inc.Tirosint | $30 | $3,46512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Lansing
- Lauren KaylorLansing$23K
- Kevin DuffyLansing$23K
- Antonio GiannelliLansing$22K
- Timothy PalmerLansing$17K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.